A clinical decision tree to predict whether a bacteremic patient is infected with an ESBL-producing organism. Goodman K, Lessler J, Cosgrove SE, Harris AD, Lautenbach E, Han JH, Milstone AM, Masey C, & Tamma PD. Tamma is an editor at Antimicrobial Agents and Chemotherapy and is a member of the Antibacterial Resistance Leadership Group Gram-Negative Subcommittee.read more Her research focuses on improving our understanding of the mechanisms of gram-negative bacterial resistance, improving available phenotypic and molecular diagnostics to identify gram-negative resistant pathogens, and optimizing therapeutic choices for infections caused by multidrug-resistant gram-negative organisms, including novel therapies like bacteriophages.ĭr.
She is the past and present recipient of federal research funding from the National Institutes of Health, Food and Drug Administration, Centers for Disease Control and Prevention, and Agency for Healthcare Research and Quality. As Director of Antimicrobial Stewardship, she assists clinicians with optimizing the selection of antibiotics to improve patient outcomes while minimizing antibiotic-associated harm. is an Associate Professor of Pediatrics in the Division of Infectious Diseases and Director of the Pediatric Antimicrobial Stewardship Program at The Johns Hopkins University School of Medicine.
0 kommentar(er)
